Global Sarcopenia Treatment Market Size study, by Treatment, by Route of Administration, by Distribution Channel and Regional Forecasts 2022-2032

Description

Global sarcopenia treatment market was valued USD 3.07 billion in 2023, growing at a compound annual growth rate (CAGR) of 4.48% during the forecast period 2024-2032. Sarcopenia, a progressive disorder marked by the gradual loss of muscle mass, strength, and physical function, predominantly impacts the aging population. Treatment approaches span across medical interventions, dietary supplements, pharmacological solutions, and physical therapy regimens aimed at mitigating muscle atrophy. With a rising geriatric demographic and growing awareness around age-related muscle degeneration, the demand for effective sarcopenia treatments is anticipated to escalate over the coming years.

The sarcopenia treatment market's expansion is driven by a confluence of factors. Key drivers include the steady rise in the global elderly population, technological advancements in musculoskeletal healthcare, and growing healthcare expenditures. In particular, the emphasis on healthy aging and maintaining muscle health through targeted therapies is fueling market growth. However, the sector also faces challenges such as low diagnosis rates, high treatment costs, and the absence of standardized care protocols for sarcopenia. Despite these barriers, significant opportunities exist in the development of personalized therapies, digital health monitoring solutions, and innovative pharmacological treatments, offering a pathway for continued market growth.

Geographically, North America leads the sarcopenia treatment market due to its robust healthcare infrastructure, a significant elderly population, and increased healthcare investments. Europe, another major player, benefits from heightened health consciousness among its aging populace. Meanwhile, the Asia-Pacific region is anticipated to experience the fastest growth, driven by a rapidly aging population, improving healthcare systems, and proactive government initiatives in countries such as Japan, China, and South Korea. The region's growing demand for advanced therapies and wellness solutions underscores its potential as a key market in the future.

Major market players in the sarcopenia treatment market include:

Nestle Health Science
Sanofi S.A.
Bayer AG
Haleon Group of Companies
Novartis AG
Abbott Laboratories
Metagenics LLC
Pfizer, Inc.
GlaxoSmithKline plc.
Makers Nutrition LLC

The detailed segments and sub-segments of the market are as follows:

By Treatment:

Protein Supplements
Vitamin B12 Supplements
Vitamin D & Calcium Supplements
Others

By Route of Administration:

Oral
Parenteral
Enteral

By Distribution Channel:

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

By Region: North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe (ROE)

Asia Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia Pacific (RoAPAC)

Latin America:

Brazil
Mexico

Middle East & Africa:

Saudi Arabia
South Africa
Rest of the Middle East & Africa (RoMEA)

Years considered for the study are as follows:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024 to 2032

Key Takeaways:

Market estimates & forecasts for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market

Chapter 1. Global Sarcopenia Treatment Market Executive Summary

1.1. Global Sarcopenia Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Treatment
- 1.3.2. By Route of Administration
- 1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Sarcopenia Treatment Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Sarcopenia Treatment Market Dynamics

3.1. Market Drivers
- 3.1.1. Growing Elderly Population
- 3.1.2. Advancements in Healthcare Technologies
- 3.1.3. Increasing Healthcare Expenditures
3.2. Market Challenges
- 3.2.1. High Treatment Costs
- 3.2.2. Limited Diagnosis Rates
3.3. Market Opportunities
- 3.3.1. Development of Personalized Therapies
- 3.3.2. Digital Health Platforms Integration
- 3.3.3. Innovative Treatment Solutions

Chapter 4. Global Sarcopenia Treatment Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Sarcopenia Treatment Market Size & Forecasts by Treatment 2022-2032

5.1. Segment Dashboard
5.2. Global Sarcopenia Treatment Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Protein Supplements
- 5.2.2. Vitamin B12 Supplements
- 5.2.3. Vitamin D & Calcium Supplements
- 5.2.4. Others

Chapter 6. Global Sarcopenia Treatment Market Size & Forecasts by Route of Administration 2022-2032

6.1. Segment Dashboard
6.2. Global Sarcopenia Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Oral
- 6.2.2. Parenteral
- 6.2.3. Enteral

Chapter 7. Global Sarcopenia Treatment Market Size & Forecasts by Distribution Channel 2022-2032

7.1. Segment Dashboard
7.2. Global Sarcopenia Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospital Pharmacies
- 7.2.2. Drug Stores & Retail Pharmacies
- 7.2.3. Online Pharmacies

Chapter 8. Global Sarcopenia Treatment Market Size & Forecasts by Region 2022-2032

8.1. North America Sarcopenia Treatment Market
- 8.1.1. U.S. Sarcopenia Treatment Market
  - 8.1.1.1. Treatment Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.2. Route of Administration Breakdown Size & Forecasts, 2022-2032
- 8.1.2. Canada Sarcopenia Treatment Market
8.2. Europe Sarcopenia Treatment Market
- 8.2.1. U.K. Sarcopenia Treatment Market
- 8.2.2. Germany Sarcopenia Treatment Market
- 8.2.3. France Sarcopenia Treatment Market
- 8.2.4. Spain Sarcopenia Treatment Market
- 8.2.5. Italy Sarcopenia Treatment Market
- 8.2.6. Rest of Europe Sarcopenia Treatment Market
8.3. Asia Pacific Sarcopenia Treatment Market
- 8.3.1. China Sarcopenia Treatment Market
- 8.3.2. India Sarcopenia Treatment Market
- 8.3.3. Japan Sarcopenia Treatment Market
- 8.3.4. Australia Sarcopenia Treatment Market
- 8.3.5. South Korea Sarcopenia Treatment Market
- 8.3.6. Rest of Asia Pacific Sarcopenia Treatment Market
8.4. Latin America Sarcopenia Treatment Market
- 8.4.1. Brazil Sarcopenia Treatment Market
- 8.4.2. Mexico Sarcopenia Treatment Market
- 8.4.3. Rest of Latin America Sarcopenia Treatment Market
8.5. Middle East & Africa Sarcopenia Treatment Market
- 8.5.1. Saudi Arabia Sarcopenia Treatment Market
- 8.5.2. South Africa Sarcopenia Treatment Market
- 8.5.3. Rest of Middle East & Africa Sarcopenia Treatment Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Nestle Health Science
- 9.1.2. Sanofi S.A.
- 9.1.3. Bayer AG
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Nestle Health Science
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Sanofi S.A.
- 9.3.3. Bayer AG
- 9.3.4. Haleon Group of Companies
- 9.3.5. Novartis AG
- 9.3.6. Abbott Laboratories
- 9.3.7. Metagenics LLC
- 9.3.8. Pfizer, Inc.
- 9.3.9. GlaxoSmithKline plc.
- 9.3.10. Makers Nutrition LLC

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes